ClinicalTrials.gg
RecruitingNCT07774936Updated Aug 19, 2026

Fetal Health Locus of Control, Maternal Anxiety, and Cardiotocography in High-Risk Pregnancies

An observational study in High-risk Pregnancy, sponsored by Istanbul Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Istanbul Training and Research Hospital · Observational

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This prospective observational cross-sectional study aims to evaluate the relationships among fetal health locus of control (FHLC) perceptions, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnant women. Pregnant women at 32 weeks of gestation or later who undergo routine non-stress testing (NST) at the Perinatology Outpatient Clinic will be invited to participate. On the same day as the routine NST, participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory. Associations between FHLC dimensions, maternal anxiety levels, and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

Read the detailed description

Fetal health locus of control reflects pregnant women's beliefs regarding the factors that determine the health of their unborn child. These beliefs may influence health-related behaviors during pregnancy. Maternal anxiety may also affect fetal heart rate regulation through autonomic and neuroendocrine mechanisms.

This study will prospectively evaluate high-risk pregnant women at 32 weeks of gestation or later who are undergoing routine non-stress testing at the Perinatology Outpatient Clinic. After written informed consent is obtained, participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory on the same day as their routine 20-minute NST.

The Fetal Health Locus of Control Scale consists of three dimensions: Internal Health Locus of Control, Chance Health Locus of Control, and Powerful Others Health Locus of Control. NST recordings will be evaluated according to FIGO-based criteria by an experienced investigator. Baseline fetal heart rate, accelerations, reactivity, decelerations, and other relevant cardiotocographic parameters will be recorded.

This study aims prospective cross-sectional evaluation of high-risk pregnant women undergoing routine non-stress testing. The primary objective is to investigate the relationships among fetal health locus of control perceptions, maternal anxiety levels, and fetal cardiotocography parameters. Secondary analyses will examine the relationships of these variables with maternal sociodemographic and obstetric characteristics.

02

Conditions studied

  • High-risk Pregnancy

Keywords

  • Fetal Health Locus of Control
  • Maternal Anxiety
  • High-Risk Pregnancy
  • Cardiotocography
03

In context

Lead sponsor

Istanbul Training and Research Hospital is the lead sponsor of 66 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women at 32 weeks of gestation or later who are being followed for a high-risk pregnancy and undergo routine non-stress testing. Participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory on the same day as their routine NST.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Singleton pregnancy at 32 weeks of gestation or later
  • Being followed for a high-risk pregnancy
  • No known diagnosed psychiatric disorder and no current psychiatric medication use
  • Absence of a fetal condition considered likely to affect the NST tracing
  • Maternal age between 18 and 45 years

Exclusion criteria

Exclusion Criteria:

  • Gestational age below 32 weeks and/or multiple pregnancy
  • Presence of a fetal condition considered likely to affect the NST tracing
  • Acute maternal infection or an obstetric emergency
  • Known diagnosed psychiatric disorder and/or current psychiatric medication use
  • Maternal age below 18 years or above 45 years
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
150 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • High-Risk Pregnant Women

    Pregnant women at 32 weeks of gestation or later who are being followed for a high-risk pregnancy and undergo routine non-stress testing. Participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory on the same day as their routine NST.

06

What researchers measure

Primary outcomes

  1. Association Between Fetal Health Locus of Control and Maternal Anxiety

    The relationship between scores obtained from the Fetal Health Locus of Control Scale and maternal anxiety measured using the Beck Anxiety Inventory will be evaluated. The Internal Health Locus of Control, Chance Health Locus of Control, and Powerful Others Health Locus of Control dimensions will be analyzed separately.

    Time frame: At the single study visit, on the same day as the routine NST

  2. Association Between Fetal Health Locus of Control and Cardiotocography Parameters

    Associations between fetal health locus of control dimensions and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

    Time frame: During the 20-minute routine NST performed at the single study visit

  3. Association Between Maternal Anxiety and Cardiotocography Parameters

    The relationship between maternal anxiety measured using the Beck Anxiety Inventory and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

    Time frame: During the 20-minute routine NST performed at the single study visit

Secondary outcomes

  1. Associations With Sociodemographic and Obstetric Characteristics

    Associations of fetal health locus of control, maternal anxiety levels, and cardiotocography parameters with maternal sociodemographic and obstetric characteristics, including age, gravidity, education level, income level, consanguinity, smoking status, and pre-pregnancy preparation, will be evaluated.

    Time frame: At the single study visit

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07774936
Lead sponsor
Istanbul Training and Research Hospital
Responsible party
Doruk Cevdi Katlan (Maternal Fetal Medicine Specialist, Istanbul Training and Research Hospital) — Principal investigator
First posted
Aug 19, 2026
Start date
Apr 14, 2026
Primary completion
May 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Aug 19, 2026

Study contacts

Doruk C Katlan
Contact
dcek2000@yahoo.com
+905353475411
Nebahat Uzunay
Contact
nebahatuzunay@gmail.com
+905052609436

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion